Venetoclax monotherapy for patients with R/R CLL: Results from the phase III VENICE-1 trial
Here we summarize the results from the VENICE-1 trial evaluating venetoclax monotherapy in patients with R/R CLL, published by Kater et al.1 in Lancet Oncology.